Research Article
Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol
Table 2
Myeloid antigen expression in childhood acute lymphoblastic leukemia in Yogyakarta, Indonesia.
| Variable | Patients (%)
| Myeloid positive (%) | Myeloid negative (%) | value |
| | | 60 (25) | 179 (75) | | Sex | | | | | Male | 139 (58) | 37 (27) | 102 (73) | 0.52 | Female | 100 (42) | 23 (23) | 77 (77) | Age | | | | | 1–9 years | 188 (79) | 49 (26) | 139 (74) | 0.51 | <1 & 10–14 yrs | 51 (21) | 11 (22) | 40 (78) | White blood cell count | | | | | <50.000/mm3 | 185 (77) | 47 (25) | 138 (75) | 0.84 | >50.000/mm3 | 54 (23) | 13 (24) | 41 (76) | French-American-British classification | | | | | ALL-L1 | 198 (83) | 44 (22) | 154 (78) | 0.02 | ALL-L2 | 41 (17) | 16 (39) | 25 (61) | Immunophenotyping | | | | | B-lineage | 183 (77) | 50 (27) | 133 (73) | 0.15 | T-lineage | 56 (23) | 10 (18) | 46 (82) | Risk classification (NCI based) | | | | | Standard risk | 95 (40) | 29 (31) | 66 (69) | 0.17 | High risk | 144 (60) | 31 (22) | 113 (79) |
|
|